What is the address of Dr. Lien Sys - Neus- Keel- en Oorziekten?

The registered office of Dr. Lien Sys - Neus- Keel- en Oorziekten is located at Beukenlaan 45, 9051 Gent.

Is Dr. Lien Sys - Neus- Keel- en Oorziekten still active?

Yes. According to the CBE (31 October 2026) Dr. Lien Sys - Neus- Keel- en Oorziekten is active, legal situation “Normale toestand”, started on 21 October 2010.

Is Dr. Lien Sys - Neus- Keel- en Oorziekten registered on Peppol?

No, Dr. Lien Sys - Neus- Keel- en Oorziekten is currently not registered on the Peppol network.

What is the enterprise number of Dr. Lien Sys - Neus- Keel- en Oorziekten?

The enterprise number of Dr. Lien Sys - Neus- Keel- en Oorziekten is BE0830521126.

When was Dr. Lien Sys - Neus- Keel- en Oorziekten founded?

Dr. Lien Sys - Neus- Keel- en Oorziekten was founded on 21 October 2010.

Who are the directors of Dr. Lien Sys - Neus- Keel- en Oorziekten?

According to the 2025 annual accounts, the directors of Dr. Lien Sys - Neus- Keel- en Oorziekten are: Lien Sys.

Is Dr. Lien Sys - Neus- Keel- en Oorziekten a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 October 2010; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Lien Sys - Neus- Keel- en Oorziekten make in 2025?

Dr. Lien Sys - Neus- Keel- en Oorziekten posted a profit after taxes of € 62,201 in financial year 2025.

What is the revenue of Dr. Lien Sys - Neus- Keel- en Oorziekten?

As a small company, Dr. Lien Sys - Neus- Keel- en Oorziekten is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 136,771.

Dr. Lien Sys - Neus- Keel- en Oorziekten (Private Limited)

Dossier Dr. Lien Sys - Neus- Keel- en Oorziekten, printed on 31 October 2026 from databakkes.be/en/0830521126/dr-lien-sys-neus-keel-en-oorziekten. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Lien Sys - Neus- Keel- en Oorziekten from Gent, company number BE0830521126, closed financial year 2025 with a result of € 62,201 after tax. For that financial year Dr. Lien Sys - Neus- Keel- en Oorziekten recorded a gross margin of € 136,771 and equity of € 400,991. Compared with financial year 2024, the result moved from € 93,296 to € 62,201. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 12, 2026.

What it is worth Growing

€ 400,991

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 62,201

▼ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4,662

▼ 50% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 12,000 paid out

19 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 2,016

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 99,137

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 129,344

▼ 25% vs 2024

€ 60,596 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 19,506

▲ 50% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 128,221 Gross margin 2022: € 128,221 First fiscal year in the series	€ 241,532 Gross margin 2023: € 241,532 ▲ 88% vs 2022 (€ 128,221) Favourable step	€ 150,012 Gross margin 2024: € 150,012 ▼ 38% vs 2023 (€ 241,532) Unfavourable step	€ 136,771 Gross margin 2025: € 136,771 ▼ 9% vs 2024 (€ 150,012) Unfavourable step	▼ 9%
Profit after taxes	€ 78,581 Profit after taxes 2022: € 78,581 First fiscal year in the series	€ 140,910 Profit after taxes 2023: € 140,910 ▲ 79% vs 2022 (€ 78,581) Favourable step	€ 93,296 Profit after taxes 2024: € 93,296 ▼ 34% vs 2023 (€ 140,910) Unfavourable step	€ 62,201 Profit after taxes 2025: € 62,201 ▼ 33% vs 2024 (€ 93,296) Unfavourable step	▼ 33%
Equity	€ 144,453 Equity 2022: € 144,453 First fiscal year in the series	€ 285,363 Equity 2023: € 285,363 ▲ 98% vs 2022 (€ 144,453) Favourable step	€ 350,789 Equity 2024: € 350,789 ▲ 23% vs 2023 (€ 285,363) Favourable step	€ 400,991 Equity 2025: € 400,991 ▲ 14% vs 2024 (€ 350,789) Favourable step	▲ 14%
Total debts	€ 110,476 Total debts 2022: € 110,476 First fiscal year in the series	€ 121,053 Total debts 2023: € 121,053 ▲ 10% vs 2022 (€ 110,476) Unfavourable step	€ 236,128 Total debts 2024: € 236,128 ▲ 95% vs 2023 (€ 121,053) Unfavourable step	€ 149,850 Total debts 2025: € 149,850 ▼ 37% vs 2024 (€ 236,128) Favourable step	▼ 37%
Cash	€ 63,187 Cash 2022: € 63,187 First fiscal year in the series	€ 42,697 Cash 2023: € 42,697 ▼ 32% vs 2022 (€ 63,187) Unfavourable step	€ 9,243 Cash 2024: € 9,243 ▼ 78% vs 2023 (€ 42,697) Unfavourable step	€ 4,662 Cash 2025: € 4,662 ▼ 50% vs 2024 (€ 9,243) Unfavourable step	▼ 50%
Land & buildings	€ 6,570 Land & buildings 2022: € 6,570 First fiscal year in the series	€ 6,026 Land & buildings 2023: € 6,026 ▼ 8% vs 2022 (€ 6,570) Unchanged	€ 5,481 Land & buildings 2024: € 5,481 ▼ 9% vs 2023 (€ 6,026) Unchanged	€ 5,133 Land & buildings 2025: € 5,133 ▼ 6% vs 2024 (€ 5,481) Unchanged	▼ 6%
Retained profit	€ 124,453 Retained profit 2022: € 124,453 First fiscal year in the series	€ 265,363 Retained profit 2023: € 265,363 ▲ 113% vs 2022 (€ 124,453) Favourable step	€ 330,789 Retained profit 2024: € 330,789 ▲ 25% vs 2023 (€ 265,363) Favourable step	€ 380,991 Retained profit 2025: € 380,991 ▲ 15% vs 2024 (€ 330,789) Favourable step	▲ 15%
Dividend	€ 33,000 Dividend 2022: € 33,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 33,000) Unchanged	€ 27,870 Dividend 2024: € 27,870 Unchanged (€ 0) Unchanged	€ 12,000 Dividend 2025: € 12,000 ▼ 57% vs 2024 (€ 27,870) Unchanged	▼ 57%
Bank debt	€ 73,220 Bank debt 2022: € 73,220 First fiscal year in the series	€ 44,115 Bank debt 2023: € 44,115 ▼ 40% vs 2022 (€ 73,220) Favourable step	€ 173,096 Bank debt 2024: € 173,096 ▲ 292% vs 2023 (€ 44,115) Unfavourable step	€ 129,344 Bank debt 2025: € 129,344 ▼ 25% vs 2024 (€ 173,096) Favourable step	▼ 25%
Balance sheet total	€ 254,929 Balance sheet total 2022: € 254,929 First fiscal year in the series	€ 406,416 Balance sheet total 2023: € 406,416 ▲ 59% vs 2022 (€ 254,929) Unchanged	€ 586,917 Balance sheet total 2024: € 586,917 ▲ 44% vs 2023 (€ 406,416) Unchanged	€ 550,841 Balance sheet total 2025: € 550,841 ▼ 6% vs 2024 (€ 586,917) Unchanged	▼ 6%

Key figures of Dr. Lien Sys - Neus- Keel- en Oorziekten, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Dr. Lien Sys - Neus- Keel- en Oorziekten?

What happened at Dr. Lien Sys - Neus- Keel- en Oorziekten in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 12, 2026 New annual accounts for financial year 2025: profit of € 62,201 (▼ 33% vs 2024). Source: NBB ↗
Oct 21, 2010 Start of the company according to the CBE. KBO
Oct 14, 2010 New establishment in Gent. KBO

In short

From € 78,581 profit in 2022 to € 62,201 profit in 2025.

Paid € 168,750 in corporate taxes since 2022.

Best year ever: 2023, with € 140,910 profit.

Paid out € 72,870 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Lien Sys

Dr. Lien Sys - Neus- Keel- en Oorziekten

Behind Dr. Lien Sys - Neus- Keel- en Oorziekten is Lien Sys.

Directors

According to the 2025 annual accounts

Lien Sys

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Beukenlaan 45

9051 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Sint - Camilliuswijk

QUANTUM TECH

€ 35,083 gross margin · 2025

Van der Vennet

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0830.521.126
VAT number: BE 0830.521.126
Registered office: Beukenlaan 45, 9051 Gent
Names & denominations: Dr. Lien Sys - Neus- Keel- en Oorziekten
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 October 2010
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗